Pluristem Therapeutics Inc (PSTI)

[zzaatt]

The market absolutely myopic.

I think the market is waiting for "Eich" of "AutoEich999" to change from a

BWAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHAHA PATHETIC DEAD MONEY

to a Strong Buy. The deep wisdom of "BWAHAHA...." is powerful indeed (bwahahaha x 200,000-196,000, LOL!)

Actually, the lack of dramatic movement today is one more indication that the "market" is a lagging indicator, and those of us who look at the achievements of PSTI just go out and buy more. The market's myopia is your opportunity (and mine). The Buerger's result is as dramatic as Dr.Lantis' reversal of his patient's advanced gangrene.

On the PLX-R18 and ionizing radiation argument, my take is that while the target patient population in the clinical trial has implications on patient recruitment, the actual results have a broad implication for ALL victims of radiation, whether it's from a nuclear blast or contamination with radioactive isotopes, or radiation treatment in a hospital.

The trial is looking for safety of PLX, and signals of efficacy. The target tissues are the same (irrespective of source of radiation). The goal is to reconstitute the ability of the damaged hematopoietic system to produce blood components. There may well be differences in the dynamics of the damage that correspond to the duration and intensity of the radiation damage, but it seems to me that any findings in this clinical trial will have broad applicability across various kind of radiation insults to the body.

This is very similar to the news today, the ability of PLX-PAD to improve the chances of a Buerger's patient has obvious (positive) implications for other syndromes where blood flow blockage is the core disease mechanism.
We have today one more piece of data that Pluristem's MSCs are going to become a major therapeutic resource in the near future.